TWST

#1561
Twist Bioscience Corporation Common Stock
57.41 USD
+13.95%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
57.41
57.41
Intervallo Annuale
23.30
57.88
Variazione giornaliera
+13.95%
Variazione Mensile
+31.76%
Variazione di 6 mesi
+84.90%
Variazione Annuale
+43.70%
Chiusura Precedente
50.38
Apertura
57.41
Bid
Ask
Minimo
57.41
High
57.41
Volume
91
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore 202020212022202320242025 TTM

Twist Bioscience Corporation

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Notizie